Oaktree Acquisition Corp.... (OACC)
NASDAQ: OACC
· Real-Time Price · USD
10.42
-0.03 (-0.29%)
At close: May 19, 2025, 2:02 PM
10.48
0.58%
After-hours: May 19, 2025, 04:00 PM EDT
Company Description
Oaktree Acquisition Corp.
III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
The company was incorporated in 2024 and is based in Los Angeles, California.
Oaktree Acquisition Corp. III Life Sciences
| Country | United States |
| IPO Date | Dec 16, 2024 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Zaid Pardesi |
Contact Details
Address: 333 South Grand Avenue Los Angeles, California United States | |
| Website | https://www.oaktreeacquisitioncorp.com/oac-iii |
Stock Details
| Ticker Symbol | OACC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001845036 |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Zaid Pardesi | Chief Executive Officer & Director |
| Courtney Conigliaro | Chief Financial Officer |
| Mathew M. Pendo | Chief Operation Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 14, 2025 | 10-Q | Quarterly Report |
| May 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 13, 2025 | SCHEDULE 13G | Filing |
| May 09, 2025 | SCHEDULE 13G | Filing |
| Mar 27, 2025 | 10-K | Annual Report |
| Oct 21, 2024 | CORRESP | Filing |
| Oct 21, 2024 | CORRESP | Filing |
| Oct 18, 2024 | CORRESP | Filing |
| Oct 18, 2024 | UPLOAD | Filing |